MSC-4106
CAS No. 2738542-58-8
MSC-4106( —— )
Catalog No. M35343 CAS No. 2738542-58-8
MSC-4106, an orally active and potent YAP/TAZ-TEAD inhibitor, disrupts TEAD1 and TEAD3 auto-palmitoylation and demonstrates significant efficacy in the NCI-H226 tumor xenograft model .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 147 | Get Quote |
|
| 5MG | 235 | Get Quote |
|
| 10MG | 377 | Get Quote |
|
| 25MG | 610 | Get Quote |
|
| 50MG | 869 | Get Quote |
|
| 100MG | 1152 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMSC-4106
-
NoteResearch use only, not for human use.
-
Brief DescriptionMSC-4106, an orally active and potent YAP/TAZ-TEAD inhibitor, disrupts TEAD1 and TEAD3 auto-palmitoylation and demonstrates significant efficacy in the NCI-H226 tumor xenograft model .
-
DescriptionMSC-4106 is an orally active and potent inhibitor of YAP/TAZ-TEAD. MSC-4106 inhibits TEAD1 or TEAD3 auto-palmitoylation and shows inhibitory effect on NCI-H226 tumor xenograft model.
-
In VitroMSC-4106 (10 μM, 24 h) inhibited SK-HEP-1 reporter and NCI-266 cell viability with IC50 values of 4 nM and 14 nM, respectively.MSC-4106 (10 μM, 6 h) crystallizes in the P-site of TEAD1, and against TEAD1 or TEAD3 palmitoylation in TEAD-Overexpressing HEK293 Cells by 97.3% and 75.9%, respectively.MSC-4106 (10 μM, 4 d) targets TEAD indicated by a reduction in viability of NCI-H226 cells.Cell Viability Assay Cell Line:NCI-H226 (YAP dependent); SW620 YAP/TAZ KO (Yap-independent) cells Concentration:0, 3, 6, 9, 12, 15, 18, 21, 24, 26, 30 μM Incubation Time:96 hours Result:Showed inhibitory effect to NCI-H226 and general cytotoxic to SW620 (IC50 >30 μM).Immunofluorescence Cell Line:SK-HEP-1Concentration:0, 3, 6, 9, 12, 15, 18, 21, 24, 26, 30 μM Incubation Time:24 hours Result:Inhibited YAP-TEAD interation.
-
In VivoMSC-4106 (100 mg/kg/d; p.o.; 7 d) displays anti-tumor effect with controlled tumor volume and good tolerability with stable body weight in mice.MSC-4106 (1, 5, 100 mg/kg/d; p.o.; 0-72 h) down-regulates Cyr61 (cysteine-rich angiogenic inducer 61) expression, the TEAD-regulated target gene, in tumor lysates at all time points at 100 mg/kg and 24 h at 5 mg/kg.Note: PO studies were performed at 10 mg/kg; MSC-4106 was formulated in 20% Kleptose in 50 mM PBS at pH 7.4.Animal Model:NCI-H226 xenograft model in H2d Rag2 female mice (9-week-old)Dosage:5, 100 mg/kg Administration:Oral gavage; once daily; 32 days Result:Resulted tumor growth controlled with 5 mg/kg while regressed with 100 mg/kg dosing after 32 treatment days.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorYAP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2738542-58-8
-
Formula Weight359.3
-
Molecular FormulaC18H12F3N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (695.80 mM; Ultrasonic )
-
SMILESCn1cc2c3cc(ccc3n(-c3ccc(cc3)C(F)(F)F)c2n1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Timo Heinrich, et al. Optimization of TEAD P-site binding fragment hit into in vivo active lead MSC-4106. J. Med. Chem. 2022, 65, 13, 9206–9229.?
molnova catalog
related products
-
Ethyl chrysanthemuma...
Ethyl chrysanthemumate is an allelochemical compound used as an attractant.
-
Gypenoside LI
Gypenoside LI possesses non-small cell lung carcinoma A549 cell inhibitory activity.
-
26Rfa, Hypothalamic ...
This human neuropeptide of the RFamide peptide family with orexigenic activity may be also involved in the control of feeding behavior. The 26RFa gene is exclusively expressed in the ventromedial hypothalamic nucleus and in the lateral hypothalamic area. The primary structures of human, rat, and frog 26RFa exhibit ≈80% identity. Other data suggest also the potential role of the 26RFa peptide in the control of the gonadotropic axis.
Cart
sales@molnova.com